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Abstract
Here we present results of a three-year study to determine the fate of imidacloprid residues
in hive matrices and to assess chronic sublethal effects on whole honey bee colonies fed
supplemental pollen diet containing imidacloprid at 5, 20 and 100 μg/kg over multiple brood
cycles. Various endpoints of colony performance and foraging behavior were measured
during and after exposure, including winter survival. Imidacloprid residues became diluted
or non-detectable within colonies due to the processing of beebread and honey and the
rapid metabolism of the chemical. Imidacloprid exposure doses up to 100 μg/kg had no sig-
nificant effects on foraging activity or other colony performance indicators during and shortly
after exposure. Diseases and pest species did not affect colony health but infestations of
Varroamites were significantly higher in exposed colonies. Honey stores indicated that ex-
posed colonies may have avoided the contaminated food. Imidacloprid dose effects was de-
layed later in the summer, when colonies exposed to 20 and 100 μg/kg experienced higher
rates of queen failure and broodless periods, which led to weaker colonies going into the
winter. Pooled over two years, winter survival of colonies averaged 85.7, 72.4, 61.2 and
59.2% in the control, 5, 20 and 100 μg/kg treatment groups, respectively. Analysis of
colony survival data showed a significant dose effect, and all contrast tests comparing sur-
vival between control and treatment groups were significant, except for colonies exposed to
5 μg/kg. Given the weight of evidence, chronic exposure to imidacloprid at the higher range
of field doses (20 to 100 μg/kg) in pollen of certain treated crops could cause negative im-
pacts on honey bee colony health and reduced overwintering success, but the most likely
encountered high range of field doses relevant for seed-treated crops (5 μg/kg) had negligi-
ble effects on colony health and are unlikely a sole cause of colony declines.
Introduction
Honey bee (Apis mellifera) colony losses and declines in native pollinators have caused much
concern worldwide [1–7]. In the United States, annual surveys conducted since the appearance
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of the syndrome known as colony collapse disorder (CCD) in 2006 continue to show consistent
losses of colonies exceeding 30%, although the incidence of CCD has declined in recent years
[8–10]. These losses threaten the economic viability of the beekeeping industry and have seri-
ous implications to pollination services for both cultivated and wild plants [11,12]. The consen-
sus among bee scientists is that honey bee colony declines are the result of multiple stressors,
working independently, in combination, or synergistically to impact honey bee health. Many
stress factors have been identified, including parasitic mites (predominantly Varroa destruc-
tor), pathogens (viruses and Nosema spp.), interaction between mites and viruses, poor nutri-
tion, pesticide exposure, management stress, and loss of foraging habitat [13–17]. While the
specific causal pathways and relative contribution of these stressors are still unknown, beekeep-
ers and many scientists assert that the extensive use of pesticides has had negative impacts on
the health of honey bees and other pollinators.
Honey bees are exposed to pesticides used within the hive by beekeepers to control parasitic
mites and pathogens, as well as to pesticides used to control pests and diseases of cultivated
plants on which bees visit for nectar and pollen. Multiple studies conducted in Europe and the
U.S. showed that both healthy and unhealthy colonies contained a diverse range of pesticides
in pollen, honey, beewax, and bees [14,18–23]. In U.S. hive surveys, miticides (fluvalinate and
coumaphos) used by beekeepers were the most frequently found, followed by pyrethroids, or-
ganophosphates, fungicides (mainly chlorothalonil), carbamates, and herbicides. In a recent
study that collected pollen from bee hives in seven major crops, 35 different pesticides were de-
tected with a total residue load ranging from 23.6 to 51,310 μg/kg from an average of 9.1 pesti-
cides per pollen sample [24]. Honey bees have probably been exposed to these pesticide loads
for many years prior to 2006, yet there has been no evidence linking hive residues of an individ-
ual chemical or combination of chemicals to recent honey bee declines, particularly the rapid
colony depopulation that is characteristic of CCD [14,16,19]. Some studies have actually
shown that residue levels of coumaphos and the pyrethroid esfenvalerate were lower in CCD-
affected colonies [14], and expression of genes involved in pesticide detoxification in collapsed
colonies was not different compared to control colonies [25].
Despite the lack of evidence implicating pesticides as a major causal factor, neonicotinoid
insecticides have been widely implicated in adversely affecting honey bee health due to their ex-
tensive use worldwide, systemic activity, and presence in pollen and nectar. These insecticides
are very effective on a broad spectrum of insect pests [26] but also moderately to highly toxic to
honey bees depending on the particular active ingredient. Six neonicotinoids, including imida-
cloprid, thiamethoxam, clothianidin, acetamiprid, thiacloprid, and dinotefuran, are applied as
systemics on many crops that require managed honey bee colonies and non-Apis bees to attain
economic yields. Neonicotinoids bind agonistically to the post-synaptic nicotinic acetylcholine
receptors in the insect central nervous system, causing spontaneous discharge of nerve im-
pulses and eventual failure of the neuron to propagate any signal [27–29]. In this study, we fo-
cused on imidacloprid because it is the most widely used and has drawn more attention to bee
health issues than other neonicotinoids. As the first neonicotinoid registered in the U.S. in
1994, imidacloprid is now generic and currently used in over 400 products, accounting for
about one-fifth of the global insecticide market [30]. Imidacloprid is also used on home gar-
dens, turf, ornamental shrubs and trees at application rates much higher than label rates for ag-
ricultural crops. For many labeled uses on agricultural crops, imidacloprid can be applied at
planting as seed coatings or soil treatments but also by chemigation, side-dress treatment, or
foliar spray during the crop cycle (including during flowering if bees are not actively foraging)
[31]. Due to their systemic activity, imidacloprid and other neonicotinoids are absorbed by the
roots or leaves and then xylem transported in the vascular system through the plant, where
they may persist for weeks or months following application depending on the application rate
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and abiotic conditions. Generally, these chemicals are less likely to move translaterally from
leaves to the fruiting structures; however, there is increasing evidence that they move to some
extent into pollen and nectar [32–35]. For these reasons, many reports claim that neonicoti-
noids, particularly imidacloprid, are the major causal factor affecting honey bee health and also
may act to trigger other stresses on bees. However, there is no scientific evidence to link neoni-
cotinoids as the major cause of colony declines [36]. A recent workshop of bee experts evaluat-
ed the relationship of 39 candidate causes to colony declines and judged neonicotinoids to be a
possible contributing factor but unlikely the sole cause [37].
Several review papers [38–40] present comprehensive accounts of the available data on resi-
due levels and exposure risks of neonicotinoids and other pesticides to bees. Of the exposure
routes outside the hive, residue studies have detected imidacloprid at average levels of 2–3.9
μg/kg in pollen and less than 2 μg/kg in nectar of seed-treated corn, sunflowers and rape
[41–43]. More recent studies of treated cucurbit crops revealed higher residues of imidacloprid
and other neonicotinoids in field-collected pollen and nectar, particularly when insecticides
were applied at higher rates and closer to flowering [34,35]. Residue levels of imidacloprid ran-
ged 24 to 101μg/kg in pollen and 7 to 16 μg/kg in nectar in pumpkin plants receiving the high
label rate, delivered as a transplant water application and later by drip irrigation during bloom
[35]. Other routes of exposure to foraging bees include residues of neonicotinoids in surface
water, guttation droplets exuded from treated corn seedlings, and contaminated talc dust from
planter exhaust [44–47]. Of the imidacloprid concentrations detected inside the hive, residues
in bees, bee bread and other hive matrices have been consistently lower than residues in pollen
collected directly from flowers and also lower and much less frequent than other pesticides.
The highest levels in pollen collected at the hive entrance have been reported in France, where
imidacloprid residues were detected in 40.5% of the samples, with levels ranging from 0.9 to
3.1 μg/kg [48,49]. In these studies, levels were either below the limit of detection or<2 μg/kg.
Other studies in Europe reported lower detection frequencies in bee-related matrices [50], and
less than 3% of the pollen samples collected from U.S. colonies contained neonicotinoid resi-
dues, of which most were the less toxic acetamiprid and thiacloprid [21]. The reported concen-
trations of imidacloprid in pollen and nectar from seed-treated crops (<5 μg/kg) are not
acutely lethal to honey bees based on dietary LD50 values. However, these residues are near to
levels shown to cause sublethal effects in laboratory studies [38]. In general, published results
suggest that exposure levels above 20 μg/kg of imidacloprid can lead to subtle physiological
and behavioral abnormalities in honey bees, including reductions in associative learning,
queen fecundity and foraging activity, as well as increased susceptibility to other stresses
[38,51–54]. For example, some studies have shown interactions of sublethal doses of imidaclo-
prid with other chemicals [55] and with the gut parasite Nosema [56], resulting in increased
susceptibility to pesticides and increased disease infection levels, respectively. While there are
demonstrated side effects on honey bees from sublethal doses of imidacloprid, laboratory re-
sults are conflicting and some disagreed with the no effects observed in field studies [37]. For
example, chronic exposure of honey bee hives for 39 days to field realistic concentrations of
imidacloprid (2–20 μg/kg) in sunflower nectar did not result in increased worker mortality or
overwintering loss [39,57]. Furthermore, most laboratory studies measured sublethal effects on
individual bees (or larvae) or small cohorts of workers by exposing them orally or topically to
single doses of pesticides in sucrose solution or contaminated pollen. These effects are most
likely less disruptive to the overall health of a functional colony than the direct effects on indi-
vidual bees. The honey bee colony, as a superorganism, can compensate for many stress factors
as a result of the social interactions and feedback mechanisms between individual bees. A
meta-analysis reported that the results of impaired learning effects from neonicotinoids ex-
posed to individual bees in laboratory tests cannot be extrapolated to a real exposure scenario
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under field conditions [58]. Thus, chronic lethal and sublethal effects of pesticide exposure
need to be assessed at the colony level.
Few field studies using honey bee colonies have examined sublethal effects of dietary expo-
sure to imidacloprid or other neonicotinoids over multiple brood cycles. One study fed replicate
colonies with repeated imidacloprid doses of 0.5 and 5 μg/kg in sucrose syrup and showed no
immediate or delayed mortality effects [57]. Several long-term studies found no detrimental ef-
fects on colonies placed during flowering in fields of clothianidin-seed treated and untreated ca-
nola [33], in oilseed rape fields treated with foliar-applied and seed-treated neonicotinoids [59],
and in tunnel cages enclosed over thiamethoxam-seed treated oilseed rape and maize [60]. A
similar study investigated the potential impact on honey bee mortality in 16 apiaries sur-
rounded by variable land use of imidacloprid seed-treated corn fields [50]. They reported a neg-
ative correlation between colony mortality rate and the acreage of treated fields, suggesting
imidacloprid had no adverse effect on colony health. Two whole colony experiments involving
sublethal exposure of neonicotinoids to honey bees showed adverse impacts on forager longevi-
ty, homing activity, and winter survival of colonies, but these studies used unrealistically high
field doses and routes of exposure [61,62]. More recently, Sandrock et al. [63] reported that sub-
lethal dietary exposure to field relevant concentrations of thiamethoxam and clothianidin had
significant negative short-term and long-term effects on colony performance and queen health.
To date, no field study has shown that imidacloprid adversely affects honey bee colony
health when directly exposed to field realistic dietary doses. Here we present results of a study
examining the chronic sublethal effects on whole honey bee colonies fed supplemental pollen
diet containing imidacloprid at field realistic doses for 12 weeks. Various endpoints of colony
performance and foraging behavior were measured during and after exposure, including winter
survival. We also present data from a related experiment that addressed the fate of imidaclo-
prid within colonies and the quantification of the actual exposure dose to worker bees, brood
and the queen via honey, beebread and royal jelly.
Methods
Sublethal Experiments
Test colonies. We conducted separate experiments using new colonies each year during
2009–10 to assess the chronic sublethal effects of prolonged exposure to imidacloprid. Colonies
were hived with starter pIcHive ackages of 900 g of bees obtained from a commercial supplier
(Wilbanks Apiaries; Claxton, GA, USA) during early April. Laying sister queens originating
from the same breeding line were used to ensure uniform genetic makeup of bees among treat-
ment groups. In each year, new hive boxes with 10 frames and plastic foundation were used to
eliminate possible carryover contamination. Colonies were located on the University of Mary-
land research farm at Beltsville, MD in areas relatively free from insecticide exposure. Crops
within the foraging range of about 3 km of the apiaries were exclusively field corn, soybean,
and small grains. None of these crops were treated with imidacloprid, although a portion of the
corn acreage was seed-treated at the low rate with other neonicotinoids. For the first four
weeks, colonies were fed sucrose syrup to allow colonies to build up before they were assigned
to treatment groups. During this period, several inspections were conducted to check queen
status and colony development. Queens were replaced if colonies became queenless or showed
signs of a weak egg-laying queen. During early May, a detailed inspection of colonies was con-
ducted to record bee strength and brood production, at which time brood frames with workers
were exchanged among hives to equalize colony strength. Colonies were then randomly as-
signed to treatment groups and relocated to isolated apiaries on the research farm. Individual
hives were placed on wood platforms spaced 10 m apart in each apiary.
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Treatment regimes. In each year, colonies were assigned to four treatment groups: no ex-
posure (control), 5, 20 and 100 μg/kg of imidacloprid. The 5 and 20 μg/kg doses represented
the reported high range of residues present in pollen and nectar in seed-treated crops. The
100 μg/kg dose was considered a worse-case exposure resulting from imidacloprid treatments
applied to crops during bloom. Residues of neonicotinoids in pollen of pumpkin plants treated
with labelled rates of imidacloprid can actually reach 100 μg/kg [35]. The experimental design
in 2009 and 2010 included ten and seven replicate colonies of each treatment, respectively.
Each of five apiaries in 2009 included two replicates of each treatment, while one replicate set
of treatments was located at seven apiaries in 2010.
Exposure method. After colonies were assigned treatment groups, they were allowed to
freely forage but each colony was provisioned with a pollen diet substitute (MegaBee, Dadant
& Sons, Inc., Hamilton, IL) either untreated or spiked with imidacloprid. Stock solutions of
imidacloprid were prepared from the formulated product [Admire Pro (42.8% a.i.), Bayer
CropScience, Raleigh, NC] and diluted in distilled water. The final concentration of each treat-
ment dose was obtained by adding the appropriate concentrated solution of imidacloprid to
heavy sucrose syrup (2 to 1 parts of sugar and water), which was then added to the MegaBee
powder in a 1.7:1 diet to sucrose solution ratio. This produced soft, moist dough which was
formed into 80 g patties. Four diet patties were placed weekly on the top bars of frames inside
each colony to allow bees ad libitum access to the pollen substitute. At each diet placement, we
removed and weighed remaining portions of the old patties to keep track of the cumulative
weight of diet consumed per colony. Pollen traps were installed at the entrance of each hive to
induce bees to consume maximum amounts of the diet. In both years, treatment regimes began
in mid May and continued for 12 weeks, ending in early August. This exposure method repre-
sented a worse-case scenario of exposure to residues entering colonies in pollen collected from
multiple bloom events of treated crops. Imidacloprid doses were either directly or indirectly ex-
posed to life stages for at least two or three brood cycles. To verify the exposure dose, samples
of fresh patties of each treatment dose and portions of patties removed after 7 days were col-
lected and analyzed for imidacloprid residues. To confirm exposure within colonies, samples of
hive bees and bee bread were also collected several times after the exposure period and analyzed
for residues.
Measured endpoints. Colonies were sampled biweekly to estimate the percentage of the
frame area covered with drawn cells, bees, capped brood, cells with older larvae, and cells
packed with beebread and honey. Each frame was carefully removed and held above the hive
box to visually estimate the percentage of area covered by each endpoint on each side. End-
points were recorded concurrently on each replicate set of treatment colonies within an apiary
by pairs of inspectors who voiced data to recorders. To minimize estimation bias, inspectors ro-
tated evenly among the different treatment colonies within each replicate set. The presence and
egg laying status of the queen was established during each inspection, either by directly observ-
ing her or freshly-laid eggs. Additional notes were recorded on any unusual presence of drone
cells, dead larvae, abnormal behavior of workers, abnormal brood pattern, and signs of disease
or pest presence. To measure foraging activity, we recorded data twice weekly on the weight of
pollen collected in the entrance traps, and data biweekly on the number of foraging bees re-
turning with and without pollen loads. Foraging counts at the hive entrance were tallied over a
5-minute period in the morning between the hours of 9 a.m. and 11 a.m.
Hive manipulations. Queen cells were removed from combs during inspections to pre-
vent swarming. During the first half of the exposure period, missing or weak queens in all treat-
ment groups were replaced to minimize breaks in brood rearing. However, there was no
manual queen replacement thereafter and colonies were left to replace queens naturally. In
both years, a second full box was added in mid-May and a super in mid-June to each colony to
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prevent overcrowding and the swarming instinct. After the treatment exposure ended in early
August, pollen traps were removed and colonies were then fed heavy sucrose syrup from mid
August through the fall using top feeder pails to build up honey stores in preparation for over-
wintering. Based on local beekeeping recommendations, each colony was given sucrose
syrup until approximately 30 kg of honey was stored or until the bees stopped feeding. In both
years, a detailed assessment of colony health and performance was made in early October to es-
timate bee strength, brood development, food stores, and queen status. Additional inspections
were conducted in January, February and March to assess food stores and
overwintering survival.
Disease determinations. In 2009, hive bees from each surviving colony were collected in
early November and again the following May for disease diagnosis. Samples containing ap-
proximately 100 bees were randomly removed from brood frames, placed in 70% alcohol, and
submitted to the USDA-ARS Bee Research Laboratory at Beltsville, MD, where they were ex-
amined for Varroamites, tracheal mites, and Nosema disease. Similarly, samples were collected
at the end of the 2010 exposure period and examined for both mites and Nosema disease.
Within-colony Fate Experiment
An additional experiment was conducted in 2011 to track the movement and degradation of
imidacloprid within whole colonies to better understand the fate of imidacloprid doses used in
the sublethal experiments. In early April, we established 24 colonies in new hive boxes (8 foun-
dation and 2 drawn frames) with 900 g packages of bees and sister queens obtained from the
same commercial supplier mentioned above. Bees were fed sucrose syrup and MegaBee diet
patties for five weeks to build up colonies before they were assigned to treatment groups. Dur-
ing mid May, hives were inspected to assess and equalize bee and brood densities and a second
full depth box with foundation frames was added to allow expansion. Colonies were then as-
signed to three treatment groups (each with 8 replicates) and relocated to four isolated apiaries,
each with two replicates of treatments. All colonies were fed 2000 g of sucrose syrup (SS) and
400 g of diet patties (DP) provisioned each week for six weeks. The control group was exposed
to untreated SS and DP. A second group was exposed to 20 μg/kg imidacloprid in SS and un-
treated DP to mimic the high range of residue exposure via contaminated nectar. The third
group was exposed to 100 μg/kg in DP and untreated SS to mimic the high range of residue ex-
posure via contaminated pollen. The spiked 2000 g of SS contained the same amount of imida-
cloprid as the spiked 400 g of DP, so all treated colonies were exposed to 40 μg of the active
ingredient each week by both routes of exposure.
At 2, 4 and 6 weeks during exposure and again at 6 weeks after exposure, we collected sam-
ples of bees, bee bread, honey, and larvae to measure residues of imidacloprid. To avoid cross-
contamination, separate collection tools were assigned to each treatment group of colonies.
Samples of 30–40 hive bees were removed by gently scooping clusters of bees from brood
frames using 250 ml snap-seal plastic containers. Older larvae (approx. 30–40) were removed
individually from brood cells using tweezers. A putty knife was used to remove a section
(approx. 9 cm2) of comb with cells packed with bee bread, which was carefully separated from
the wax cells using tweezers and probes. Honey was removed with plastic containers to scrape
up through capped cells, allowing honey to ooze out. Additionally, we removed all queens after
five weeks of exposure to trigger queen cell formation and production of royal jelly. Five days
later, grafting tools were used to scoop out royal jelly from queen cells. Queens removed were
banked in other colonies until enough royal jelly was collected and then returned to their re-
spective hives. All samples in the field were stored on ice in coolers and then frozen immediate-
ly to -80 C., after which they were further processed in the laboratory. For most samples, we
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collected quantities greater than 3 g in order for the chemical analysis to measure residues at
the lowest detection level; however, there were some samples of larvae that were less than 3 g.
Possible treatment effects on queen health and colony performance were also monitored
every two weeks during the entire experiment. A third hive box was added after exposure to
allow space for further colony expansion. Full inspections of frames to record endpoints of bee
strength, brood and food stores were made after 4 and 6 weeks of exposure according to the
methods described above. Less quantitative inspections were conducted at 2, 4 and 6 weeks
after exposure by recording the number of inner spaces between frames with clusters of bees,
number of frame sides with stored honey and beebread, and the number of frame sides covered
with at least 25% capped brood and larval cells. Colonies were fed sucrose syrup for several
weeks starting on late August, and then a final inspection was made on 24 September to assess
the cumulative impact of the treatments. Colonies were rated ‘weak’ (missing queen, very little
brood and stored food), ‘medium strength’ (queen and brood but low in stored food), and
‘strong’ (queen, brood and sufficient stores of food present).
Residue Analysis
Samples of bees and other hive matrices from all experiments were analyzed for residue levels
of imidacloprid and its major metabolites (imidacloprid olefin, 5-hydroxy imidacloprid, 6-
chloronicotinic acid, imidacloprid urea, desnitro imidacloprid olefin, and desnitro imidaclo-
prid HCl). All samples were processed by the Analytical Chemistry Branch, Biological and
Economic Analysis Division, Office of Pesticide Programs, U.S. EPA at Fort George G.
Meade. Sample preparation, calibration standards, and residue analysis using liquid chroma-
tography−tandem mass spectrometry (LC-MS/MS) were preformed according to the method
protocol described in [64,35]. The limit of detection was 0.2 for imidacloprid and 0.2–15 μg/kg
for the metabolites.
Statistical Analysis
Estimates of individual frame area covered by each measured endpoint at each inspection were
weighed according to the size of the hive box (i.e. lower weight assigned to super frames) and
then averaged over all frames per colony. For bee strength, a linear regression function was
used to estimate the number of hive bees per colony from the percentage frame area covered
with bees [65]. Exact estimates of bee strength were not possible because colonies were in-
spected during the day when foragers away from the hive were not included. A mixed model
ANOVA procedure (SAS Institute, version 9.1.3) was used to test for treatment effects on colo-
ny performance and foraging. Each colony represented a single experimental unit and apiaries
were treated as a random blocking factor. All data sets were evaluated before analysis for nor-
mality and homogeneity of variances by examining residual plots and Shapiro-Wilk statistic.
For data not meeting the assumptions of ANOVA, the arcsine transformation for percentages
or other appropriate transformations were used or variances were grouped among subsets of
treatment groups prior to analysis. For endpoints measured over time, inspection date was
treated as a fixed factor and the repeated measures option was used to correct for autocorrela-
tion among inspections. Means were separated following a significant F test by using Tukey’s
multiple comparison adjustment (p< 0.05). For endpoints with non-significant interaction ef-
fects, contrasts and adjusted p values were computed comparing the overall treatment effect
with the control.
Additional tests were performed to examine the dose effect on endpoints of overall colony
performance using linear regression. Here, we converted the data collected for each endpoint
over inspection dates to cumulative area under the curve (AUC) values. Area at each inspection
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was derived by averaging the endpoint measurement over two sequential inspection dates and
multiplying by the number of days between dates. Area values were then accumulated over the
entire exposure and post exposure period. Regression analysis fitted a linear model with expo-
sure dose to the total area value of each colony endpoint. We also used Fisher’s Exact Test to
determine if the frequency of queen events and overwintering survival were significantly relat-
ed to the exposure dose. To increase statistical power, we combined data over both years on the
number of surviving colonies at the October, February and March inspection dates. We used
the GLIMMIX procedure of SAS to fit a logistic regression model with exposure dose to the
proportion surviving over the three dates. The analysis accounted for a random year effect and
adjusted for autocorrelation among months within each year. Contrast tests with Tukey’s mul-
tiple comparison adjustment (p< 0.05) determined if overall survival of the exposed colonies
at each treatment dose was significantly different from survival of the control colonies. For the
residue analysis data, levels of the parent and metabolite compounds in bees, hive matrices,
and diet patties were averaged to calculate means and ranges for each treatment dose. Non-
detected samples were scored a value of zero for calculating means or in some cases means
were computed using only positive detections to show upper range exposure levels. Regression
analysis and Spearman correlations tested the degree of association between disease occurrence
in colonies (incident and severity of mites and Nosema spores) and dose of
imidacloprid exposure.
Results
2009 Sublethal Experiment
Imidacloprid exposure. Exposure doses were confirmed by residue levels in partially-con-
sumed patties removed after 7 days, which averaged 0.0, 5.5, 19.8 and 97.5 μg/kg of imidaclo-
prid from the control, 5, 20 and 100 μg/kg colonies, respectively. Weekly consumption of diet
patties varied significantly over the exposure period (F(11, 428) = 4.31, p<0.001) but was not dif-
ferent among treatment groups, which ranged from 265.3 to 277.2 g per colony. Based on total
consumption over 12 weeks, each colony of the 5, 20 and 100 μg/kg treatment groups was ex-
posed to an average cumulative dose of 16.6, 63.7 and 322.6 mg of imidacloprid, respectively.
Imidacloprid and several metabolites were present in 40% of the bee samples and 68% of the
bee bread collected from colonies in August (end of the exposure period). Of the positive detec-
tions, residues ranged from 0.3 to 2.8 μg/kg in bees and 0.4 to 1.6 μg/kg in beebread, and were
generally higher with increasing exposure dose. Only traces of residues (<0.4 μg/kg) were de-
tected in 24% of the bee samples collected in October, whereas residues in 85% of the bee bread
samples were consistently higher than levels in August but not correlated with exposure dose
(r = 0.282; p = 0.145). Less than 5% of the control samples had trace amounts of imidacloprid.
Bee bread residues of the positive samples averaged 0.7, 1.2, 2.8 and 2.2 μg/kg in bee bread
from the control, 5, 20 and 100 μg/kg treatment groups, respectively.
Colony health. No colonies showed any evidence of overcrowding, unusual queen cell for-
mation, or swarming behavior during or after the exposure period. The number of queen cells
of all types summed over inspections was not significantly affected by the treatments (F(3, 31) =
0.87, p = 0.47). Eleven queen events occurred at different times among the 40 colonies, and the
frequency of events was positively associated with the exposure dose (p = 0.009, Fisher’s Exact
Test). Of these events, a weak queen in one control colony was replaced manually in late June,
while supersedural events occurred during late summer in 2, 4 and 4 colonies exposed to 5, 20
and 100 μg/kg doses, respectively. All colonies survived to enter overwintering, except for two
colonies in each higher dose groups, which became too weak after queens were naturally re-
placed and thus had to be terminated in early September to avoid robbing.
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All colonies sampled in the fall were infested with Varroamites at average (±SE) densities
of 7.1 ±1.4, 8.8 ±2.6, 6.6 ±1.2 and 13.3 ±3.0 mites per 100 bees from the control, 5, 20 and
100 μg/kg treatment groups, respectively. Mite counts in colonies exposed to the high dose
were significantly higher than the control group based on a contrast test of the difference
(F(1, 28.4) = 4.31, p = 0.047). Furthermore, Varroa infestations showed a positive linear relation-
ship with imidacloprid dose (p = 0.03). Only three colonies (two exposed to 5 μg/kg; one ex-
posed to 20 μg/kg) in the fall tested positive for Nosema spores (< 1.5M spores per bee). Of the
colonies that survived to the following spring, Varroa densities ranged from 6.7 to 9.0 mites
per 100 bees and were not significantly different among treatment groups. Eleven of the 27 col-
onies that survived the winter were infected with Nosema spores (< 2.2M spores per bee) but
spore counts were not positively associated with exposure doses. Dead bees and queens from
seven colonies that died during the winter were also analyzed for Nosema spores and only one
colony in each 5 and 20 μg/kg exposed groups tested positive.
Colony performance endpoints of bees, capped brood cells, food stores and drawn out cells
showed no significant dose effects at the end of the exposure period (S1 Table, Fig. 1). The only
difference observed was the consistently higher levels of honey stores in exposed colonies com-
pared to the control (contrast test: F(1, 31.1) = 4.63, p = 0.039). This effect was also supported by
a significant linear positive relationship between the cumulative AUC values for capped honey
and imidacloprid dose (p = 0.02). Fig. 2 shows the mean bee colony size and percentage of
frame area with capped brood over all inspection dates for each exposure group of surviving
colonies. These endpoints varied significantly over inspection dates but were not significantly
affected by dose or its interaction with date. The colony size (±SE) averaged over all dates was
17,440 ± 546, 18,541 ± 565, 17,813 ± 540 and 18,850 ± 448 bees in the control, 5, 20 and
100 μg/kg treatment groups, respectively. However, as mentioned above, two colonies in each
of the higher dose groups were terminated in early September; thus, means of the last two in-
spection dates for these groups are based on the eight surviving colonies. Interestingly, regres-
sion results showed a near significant dose relationship (p = 0.054) with cumulative AUC
values of bee numbers, indicating higher overall colony size with higher exposure doses.
Dose relationships using AUC values were not significant for capped brood cells and older lar-
vae (p = 0.54), pollen (p = 0.75), queen cells (p = 0.19), and drawn cells (p = 0.13).
Of the remaining colonies surviving on October 6, we found no significant differences in
the cells drawn, capped honey, bee bread, capped brood and bees (Fig. 3, S2 Table), although
Fig 1. Colony performance endpoints of the 2009 colonies exposed for 12 weeks to untreated or
imidacloprid-spiked diet patties.Means (±SE) are given for each endpoint recorded at the end of exposure
(August 6).
doi:10.1371/journal.pone.0118748.g001
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honey stores in the 20 and 100 μg/kg exposed colonies were consistently higher at the August
and October inspections. Despite similar performance endpoints among treatments prior to
overwintering, the higher rates of queen events and resultant breaks in brood rearing at the
higher doses apparently weaken colonies during the winter, resulting in lower survival. We
considered colonies to have successfully overwintered if they survived to the March inspection
with an active queen with brood and were able to buildup in the spring. Out of ten replicate col-
onies in each treatment group, 10, 8, 7 and 6 colonies survived the winter from the control, 5,
20 and 100 μg/kg groups, respectively. Hive inspections of die-off colonies showed smaller clus-
ters that either could not reach the stored honey or were over-chilled but there were no food
shortages or symptoms of colony collapse disorder related to winter mortality. Using Fisher’s
one-tailed Exact Test, only the difference in winter survival between the control and 100 μg/kg
exposed colonies was statistically significant (p = 0.043).
Foraging measurements. The amount of pollen collected twice weekly in the entrance
traps showed a significant time effect (F(20, 690) = 28.04, p< 0.001) but no dose (p = 0.37) or
Fig 2. Mean (±SE) colony size and percentage of capped brood cells in the 2009 colonies exposed to
untreated or imidacloprid-spiked diet patties for 12 weeks (May 15 to August 8). ANOVA results for
bees (dose: F(3, 26.7) = 0.99, p = 0.414; date: F(8, 281) = 75.25, p< 0.001; interaction: F(24, 281) = 1.13,
p = 0.311) and brood (dose: F(3, 25.9) = 0.06, p = 0.980; date: F(8, 279) = 68.27, p< 0.001; interaction:
F(24, 279) = 0.69, p = 0.859).
doi:10.1371/journal.pone.0118748.g002
Fig 3. Colony performance endpoints (mean±SE) of the 2009 colonies recorded on October 6 prior to
overwintering (two months after exposure).
doi:10.1371/journal.pone.0118748.g003
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interaction (p = 0.99) effects on foraging success. Pollen collected by the control, 5, 20 and
100 μg/kg exposed colonies averaged 56.6 ± 3.0, 60.8 ± 2.9, 57.6 ± 2.6 and 59.8 ± 2.3 g (±SE)
per day, respectively. No effect was further indicated by a non-significant regression relation-
ship between the cumulative AUC values for collected pollen and imidacloprid dose (p = 0.81).
We also found no significant main dose or interaction effects on the number of foragers return-
ing to each hive, which ranged from 206 to 217 bees per 5 minutes; and no dose and interaction
effects on the percentage of bees loaded with pollen pellets (Fig. 4). However, foraging activity
of the exposed colonies was significantly 12% lower than that of control hives during August
and September (contrast test: F(1, 28.7) = 5.50, p = 0.026).
2010 Sublethal Experiment
Imidacloprid exposure. The second year experiment followed the same protocol used in
2009, except for only seven replicates per treatment and that the 12 week exposure ended later
in August. Individual colonies in treatment groups consumed similar amounts of diet patties,
ranging from an average of 58.8 to 61.7 g per day. Exposure doses were confirmed by residues
in both old and fresh treated patties, all of which were within ± 5% of the targeted concentra-
tions of 5, 20 and 100 μg/kg. Imidacloprid presence in the control colonies was non-detectable,
while residues in bees and beebread collected from exposed colonies were less frequently de-
tected and lower than levels found in 2009. Residues of 0.3–2.2 μg/kg in bees were detected
after four weeks of exposure in two colonies exposed to 100 μg/kg, while only trace amounts of
imidacloprid (< 0.5 μg/kg) in bees were detected in three of the 28 colonies sampled on August
19. Beebread samples collected from all colonies on June 30, August 16 and October 7 showed
imidacloprid residues ranging from 0.2 to 4.1 μg/kg in only 4 or 5 exposed colonies on each
date. These residues consistently decreased after exposure and were not related to
exposure dose.
Colony health. Similar to the 2009 experiment, colonies expanded in size without any
signs of swarming by utilizing space in hive boxes added during the early summer. However,
unlike the 2009 results, the frequency of queen events was not associated with exposure dose
(p = 0.83, Fisher’s Exact Test), nor was there a significant regression relationship between the
number of supersedural cells and dose (p = 0.70). Control and 5 μg/kg exposed colonies
Fig 4. Mean (±SE) percentage of foragers with pollen pellets and the number of foragers returning to
the 2009 colonies exposed to untreated or imidacloprid-spiked diet patties. ANOVA results for the
percentage loaded with pollen (dose: F(3, 93.6) = 0.53, p = 0.662; date: F(7, 176) = 17.81, p< 0.001; interaction:
F(21, 177) = 0.39, p = 0.993) and number of foragers (dose: F(3, 86.8) = 0.43, p = 0.733; date: F(7, 177) = 11.78, p
< 0.001; interaction: F(21, 178) = 1.02, p = 0.445).
doi:10.1371/journal.pone.0118748.g004
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actually experienced nine queen events compared to five events in colonies exposed to the
higher doses. All colonies sampled on August 19 were infested with Varroamites at average
densities (±SE) of 2.0±0.39, 1.8±0.56, 2.9±0.99 and 3.9±0.82 mites per 100 bees from the con-
trol, 5, 20 and 100 μg/kg treatment groups, respectively. Although mite counts were not signifi-
cantly different among treatment groups (F(3, 23) = 2.01, p = 0.14), regression results showed a
significant increasing trend with exposure dose (p = 0.043). Only one control and two treated
colonies tested positive for low levels of Nosema spores.
The process of hiving packages of bees started later in April and cooler temperatures slowed
the build-up of colonies; thus, bee populations were overall lower than those in 2009. Colony
population estimates (±SE) across all inspection dates averaged 13,822±600, 14,200±790,
13,813±690 and 14,140±613 bees in the control, 5, 20 and 100 μg/kg treatment groups, respec-
tively. The number of bees per colony and percentage of frame area covered with brood
(capped cells and older larvae) varied over inspection dates but were not significantly affected
by the exposure dose (Fig. 5). Brood production significantly changed over the season, with ex-
pected higher levels in all colonies during June, lowest during July, and then a gradual increase
through to September. Note that the brood was lowest in control colonies during late July
through early September due to a higher frequency of queen events and subsequent breaks in
reproduction. Although the dose and interaction effects were not significant, a contrast test
showed a significant difference in brood production between the control group and exposed
colonies grouped together (F(1,186) = 6.22, p = 0.014). An analysis of hive inspection data on
August 19 after exposure ended revealed no significant dose effects on any of the colony perfor-
mance endpoints (Fig. 6, S3 Table). Although the 100 μg/kg exposed colonies stored higher
amounts of honey on August 19, consistent with results in 2009, the relationship between the
honey stores based on AUC values accumulated over all dates and exposure dose was not sig-
nificant (p = 0.98). Dose relationships using AUC values were also not significant for bee num-
bers (p = 0.92), capped brood cells and older larvae (p = 0.85), pollen (p = 0.25), queen cells
(p = 0.70), and drawn cells (p = 0.92).
All colonies survived to the last inspection (October 7), except for one replicate in each ex-
posed group. These colonies died out during September due to a lack of brood and virtually no
stored food, despite the fact that each hive was provisioned with sucrose syrup since mid-
Fig 5. Mean (±SE) colony size and percentage of capped brood cells in the 2010 colonies exposed to
untreated or imidacloprid-spiked diet patties for 12 weeks (May 27 to August 19). ANOVA results for
bees (dose: F(3, 23.7) = 0.04, p = 0.988; date: F(7, 165) = 7.69, p< 0.001; interaction: F(21, 165) = 3.89, p = 0.608)
and brood (dose: F(3, 18.3) = 0.34, p = 0.800; date: F(7, 146) = 8.64, p< 0.001; interaction: F(21, 146) = 1.16,
p = 0.296).
doi:10.1371/journal.pone.0118748.g005
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August. Of the remaining colonies going into the winter, results showed no significant differ-
ences in colony size, brood or food stores among treatment groups at the last inspection (Fig. 7,
S4 Table). However, several colonies in the control and exposed groups contained less than the
6 kg of stored honey going into the winter. Overall winter survival was much lower than the
levels experienced in 2009 as a result of over-consumption of food stores due to a mild winter.
On February 7, hive inspections revealed 2, 2, 3 and 3 dead colonies in the control, 5, 20 and
100 μg/kg treatment groups, respectively, and most of these colonies were low in food stores
and had to be provisioned with bee candy. A final inspection on March 17 confirmed another
dead colony in each of the control and 5 μg/kg treatment groups. Of the 12 colonies that died
out during the winter, only two hives lacked stored food which most likely led to starvation.
Out of seven replicate colonies, 4, 3, 3 and 3 in the control, 5, 20 and 100 μg/kg groups, respec-
tively, were able to successfully overwinter; however, Fisher’s one-tailed Exact Test showed no
statistically significant (p = 0.21) in the proportions of overwintered colonies. After the March
inspection, all remaining colonies were fed sucrose syrup in top feeders and were able to build-
up normally in the spring.
Fig 6. Colony performance endpoints of the 2010 colonies exposed for 12 weeks to untreated or
imidacloprid-spiked diet patties.Means (±SE) are given for each endpoint recorded at the end of exposure
(August 19).
doi:10.1371/journal.pone.0118748.g006
Fig 7. Colony performance endpoints (mean±SE) of the 2010 colonies recorded on October 7 prior to
overwintering (about seven weeks after exposure).
doi:10.1371/journal.pone.0118748.g007
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Foraging measurements. The amount of pollen collected at the entrance of colonies var-
ied widely over the season in response to changes in foraging sources but was not significantly
different among treatment groups (F(3,24.1) = 0.41, p = 0.75). Regression results also showed no
significant relationship between the cumulative AUC values for collected pollen and imidaclo-
prid dose (p = 0.88). Control, 5, 20 and 100 μg/kg exposed colonies collected an overall average
(±SE) of 29.8±2.26, 35.1±2.93, 39.4±3.74 and 34.1±2.97 g of pollen per day, respectively. These
levels were 41% less than the weight of pollen collected by the 2009 colonies, which had 31%
more forager bees on average. Control colonies collected significantly less pollen during July
due to breaks in brood rearing and reduced bee strength. Foraging activity recorded five times
during the exposure period showed no evidence of any dose or interaction effects on the total
number of foragers returning or the percentage of bees loaded with pollen pellets (Fig. 8). Over-
all, an average of 151 to 159 foragers returned per 5 min and 38 to 40% were loaded
with pollen.
2011Within-hive Fate Experiment
This study provided information on the actual within-hive residues of imidacloprid that was
relevant to exposure doses used in the sublethal experiments, particularly residues in bees and
brood resulting from contaminated diet patties. Table 1 summarizes the frequency of positive
detections and range of imidacloprid residues found in various hive matrices at different collec-
tion times. The majority of the 87 samples from the control colonies had non-detectable resi-
dues, although eight showed trace levels that were apparently due to drifting or possible cross-
contamination during sampling. For unexplained reasons, one bee sample collected after 2
weeks of exposure from an untreated colony contained 2.9 μg/kg and was analyzed twice for
confirmation. Since this value lies more than 1.5 times outside the interquartile range of the
residue data, it was considered an outlier and possibly due to a mislabeled sample. The frequen-
cy of positive detections and residue levels were significantly higher in colonies fed 100 μg/kg
diet patties compared to residues in colonies fed 20 μg/kg sucrose syrup. Totaled over all hive
matrices, 77.1 and 19.4% of the samples collected during exposure from colonies fed treated
diet patties and sucrose syrup, respectively, contained residues of imidacloprid. The highest
levels were found in honey (average 6.5–7.2 μg/kg) collected from colonies exposed to treated
Fig 8. Mean (±SE) percentage of foragers with pollen pellets and the number of foragers returning to
the 2010 colonies exposed to untreated or imidacloprid-spiked diet patties. ANOVA results for the
percentage loaded with pollen (dose: F(3, 42.6) = 0.85, p = 0.473; date: F(4,81.7) = 18.93, p< 0.001; interaction:
F(12,82.2) = 0.93, p = 0.520) and number of foragers (dose: F(3,34) = 1.13, p = 0.350; date: F(4,80.8) = 8.64, p<
0.001; interaction: F(12,80.9) = 0.71, p = 0.742).
doi:10.1371/journal.pone.0118748.g008
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diet patties, followed by lower but consistent levels in bees (average 0.3–0.7 μg/kg) and bee-
bread (average 0.9–1.0 μg/kg). Residues in larvae were non-detectable, except for one sample
collected after 2 weeks of exposure in each treatment group. At 6 weeks after exposure, residue
levels were slightly lower but the frequency of positive samples remained about the same in
bees, beebread and honey from colonies fed diet patties with 100 μg/kg of imidacloprid. In con-
trast, residues in colonies fed 20 μg/kg in sucrose syrup declined more quickly after exposure.
All samples of royal jelly from colonies fed 100 μg/kg diet patties had detectable levels of imida-
cloprid residues, ranging from 0.3 to 1.0 μg/kg (average 0.6 μg/kg), whereas no royal jelly sam-
ples from colonies fed treated sucrose syrup contained detectable levels. Residues of the
imidacloprid metabolites (olefin, 5-hydroxy, urea, desnitro olefin, and chloronicotinic acid)
were not detected in any of the samples. However, the LOD levels were higher (ranging from
0.4 to 4.4 μg/kg) for these degradates.
Overall colony performance of the three treatment groups provided additional data on the
sublethal effects of imidacloprid. Colony size was not significantly affected by the two exposure
routes during the 6-week period (F(2, 28.6) = 0.63, p = 0.54). Hive populations averaged 14,001
±476, 13,890±408 and 13,080±338 bees per colony in treatment groups exposed to untreated
food, 20 μg/kg sucrose syrup, and 100 μg/kg diet patties, respectively. However, bee strength
measured during August inspections showed significant differences in the number frames with
bees (F(2, 14) = 8.44, p = 0.004). Colonies fed 100 μg/kg diet patties had 14–26% fewer frames of
bees than the control colonies or colonies fed 20 μg/kg sucrose syrup. All other endpoints in-
cluding brood rearing and food stores were not significantly affected by the exposure routes.
All eight colonies in each treatment group were active on September 24 but 3, 4 and 4 colonies
Table 1. Residues of imidacloprid in hive matrices resulting from feeding spiked Mega-bee diet patties and sucrose syrup to honey bee
colonies for six weeks.
Treatmenta Sample duration Number of colonies with positive detections/total samples
(Range of imidacloprid residuesb (μg/kg) in positive samples)
Bees Beebread Larvae Honey Royal jelly
Colonies fed diet patties (100 μg/kg imidacloprid) and
untreated sucrose syrup
2 weeks exposure 6 / 8 (0.2–
1.4)
8 / 8 (0.5–
1.7)
1 / 8
(0.4)
7 / 8 (4.7–
13.4)
NA
6 weeks exposure 5 / 8 (0.5–
1.9)
8 / 8 (0.6–
1.2)
0 / 8
(ND)
7 / 8 (2.8–
10.8)
8 / 8 (0.3–
1.0)
6 weeks after
exposure
8 / 8 (0.3–
0.5)
8 / 8 (0.8–
1.4)
0 / 7
(ND)
8 / 8 (2.3–
11.7)
NA
Colonies fed sucrose syrup (20 μg/kg imidacloprid) and
untreated diet patties
2 weeks exposure 3 / 8 (0.2–
0.5)
2 / 8 (0.7–
1.0)
1 / 8
(0.5)
4 / 8 (0.2–
3.7)
NA
6 weeks exposure 0 / 8 (ND) 3 / 8 (0.2–
0.9)
0 / 8
(ND)
1 / 8 (0.9) 0 / 8 (NA)
6 weeks after
exposure
0 / 8 (ND) 2 / 8 (0.2–
0.3)
0 / 5
(ND)
2 / 8 (0.2–
0.5)
NA
Colonies fed untreated diet patties and sucrose syrup 2 weeks exposure 4 / 8 (0.2–
2.9)
1 / 8 (1.1) 0 / 6
(ND)
0 / 8 (ND) NA
6 weeks exposure 0 / 8 (ND) 0 / 8 (ND) 0 / 6
(ND)
0 / 8 (ND) 0 / 6 (ND)
6 weeks after
exposure
0 / 8 (ND) 0 / 8 (ND) 0 / 4
(ND)
3 / 7 (0.2–
0.3)
NA
aAll colonies were fed 2000 g of sucrose syrup and 400 g of diet patties weekly for six weeks; thus each colony was exposed to 40 μg of imidacloprid
per week.
bLOD = 0.2 μg/kg; LOQ = 0.6 μg/kg; ND = non-detectable; NA = not sampled.
doi:10.1371/journal.pone.0118748.t001
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in the control, 20 μg/kg sucrose syrup, and 100 μg/kg diet patty groups, respectively, were rated
weak with very little brood and stored food. Nearly an equal number of colonies in each group
were rated either medium strength or strong. A contingency table X2 analysis indicated that
the proportions in each rating were independent of the treatment group (p = 0.98). After the
last inspection, weak colonies were combined with stronger ones for overwintering and no fur-
ther data were recorded.
Discussion
Imidacloprid exposure and hive residues. We designed the sublethal experiments to
directly expose bees to known doses of imidacloprid as the only stressor and to force colonies
to consume a significant portion of their protein requirement from the Mega-bee diet patties.
MegaBee protein supplement is readily consumed by bees at about the same rate and closely
resembles the nutritional value of pollen [66,67]. The patties contained approximately 16%
protein and 37% carbohydrates based on the ratio of water, sucrose and Mega-bee powder. The
daily consumption rates of diet patties (30–60 g) provided enough protein to support the daily
development of up to 1260 larvae [68] or 1477 nurse bees [69]. In the same way, the consumed
amount of sugar in patties was enough to support the daily development of up to 376 larvae, 70
brood bees, or 246 forager bees [69]. Though we cannot equate MegaBee diet consumption
directly to bee-collected pollen or nectar, diet patty consumption alone provided a significant
portion of the daily nutritional requirements of the colonies.
The presence of imidacloprid in bees and beebread collected weeks after exposure provided
evidence that colonies were exposed for at least two or possibly three development cycles of
brood. Residue levels were generally higher in beebread than in bees and more consistent in
samples from colonies exposed to the higher treatment doses. Average residue levels of the pos-
itive detections ranged up to 3.7 μg/kg, and the majority of bee and beebread residues exceeded
concentrations of imidacloprid found in bee-collected pollen, honey and bees reported from
colony surveys [41–43,50]. It also is noted that traces of imidacloprid were detected in a few
samples from control colonies in 2009, and this cross-contamination was apparently due to
drifting and possibly some robbing because hives were placed close to each other in apiaries.
Averaged across all negative and positive samples, these residues were well below levels found
in treated colonies, were probably introduced into control colonies after the exposure period,
and were not detected in the 2010 sublethal study. Nevertheless, this contamination under-
scores the importance of closing out declining colonies before robbing occurs, and taking the
necessary steps to avoid contamination while sampling.
The within-hive fate experiment provided insights into the relative levels and distribution of
imidacloprid residues among hive matrices resulting from doses used in the sublethal experi-
ments. Colonies that were fed diet patties spiked with 100 μg/kg for six weeks showed residue
levels in bees, beebread and honey that were close to or exceeded those dietary doses of imida-
cloprid that caused sublethal effects in the laboratory [38]. In particular, nearly all honey sam-
ples had detectable imidacloprid residues ranging from 2.3–13.4 μg/kg, even six weeks after
exposure and more than 10 times higher than residues in bees and beebread. Residues were
probably concentrated by the evaporative processing of nectar. Surprisingly, we expected
higher residue levels in honey from colonies fed treated sucrose syrup, which exposed bees to
the same quantity of imidacloprid each week. This suggests that hive bees were utilizing diet
patties differently from the way bee-collected pollen is processed. It is generally agreed that pol-
len diet supplements are processed for food quickly and not stored for long periods of time.
Laboratory feeding studies using marker dyes in diet patties have also demonstrated rapid de-
position of the dye in bees [70]. The residue levels in honey were several times higher than the
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reported concentrations of imidacloprid in pollen collected from seed-treated sunflower, maize
and canola [39,41–43] and even higher than residues found in beebread, honey and wax sam-
ples collected from colonies [50,21]. Imidacloprid residues in bees dropped to lower or non-de-
tectable levels and were relatively absent in larvae at six weeks after exposure, whereas levels in
beebread and honey remained relatively stable. The residue concentration in bees and larvae
was probably reduced by the rapid metabolism of imidacloprid, which has a reported half-life
of 4–5 hours in the honey bee [71,28], and further diluted by the addition of bee-collected un-
contaminated nectar and pollen entering the colonies. In view of the glandular secretion and
processing involved in producing royal jelly, we were surprised that all samples of royal jelly
tested positive for imidacloprid residues. Residues in stored honey, larvae and royal jelly were
not analyzed in the sublethal experiments; however, all life stages in the exposed colonies may
have been subjected to higher levels of imidacloprid than the levels detected in beebread, as-
suming the same relative distribution of residues in hive matrices shown in the within-hive fate
experiment. Based on the overall residue results, we would argue that the high dose of 100 μg/
kg exposed continuously in diet patties for 12 weeks represented a worst-case scenario of field
exposure to imidacloprid at the whole colony level.
Effects on foraging activity. Several laboratory and semi-field studies have shown that the
sublethal effects of imidacloprid can interfere with food collection by affecting the longevity, ol-
factory learning and orientation functions of foraging bees (reviews in [38,58]). However, these
effects have not been demonstrated at the colony level under relevant field exposure conditions.
In our studies, we assumed that exposure to contaminated nectar or water while foraging was
minimal because apiaries were isolated from any bee-attractive crops that may have been treat-
ed with imidacloprid. More likely, foragers returning to the treated colonies were either ex-
posed to imidacloprid residues by consuming honey in the colony, or exposed earlier in their
life as larvae fed brood food or as young nurse bees consuming pollen. This cumulative expo-
sure could lead to subtle adverse effects on longevity, learning ability and homing behavior of
forager bees. However, we found no evidence that imidacloprid affected foraging activity dur-
ing and after exposure in both sublethal experiments. The number of foragers returning and
percentage loaded with pollen pellets changed significantly over time in response to seasonal
pollen sources but neither treatment nor its interaction with time had a significant effect on
these endpoints. The weight of bee-collected pollen trapped at the hive entrance was consid-
ered a direct measure of foraging success. There were no significant differences in pollen
weights among treatment groups in both sublethal experiments, except for the 2010 control
colonies that collected less pollen during July than treated colonies due to lower bee popula-
tions. Interestingly, the overall amount of pollen trapped approximated closely the weight of
diet patties consumed per day by each colony. Hive bees apparently were forced to utilize the
diet patties for nutrition in place of pollen removed by the entrance traps. This further indicates
that bees and brood were exposed to relatively high dietary concentrations of imidacloprid.
Other field studies have examined foraging behavior of bees fed sublethal doses of imidaclo-
prid in sucrose water to represent exposure via contaminated nectar. Schneider et al. [72] fed
individual foragers spiked sucrose solutions and recorded no effect on foraging behavior at imi-
dacloprid doses of 1.9 μg/kg by bee weight but less foraging activity and longer foraging flights
at 10x higher doses. Bortolotti et al. [73] showed no effects on the number of returning foragers
but delays in return flights to feeding sites when bees were fed 100 μg/kg in sucrose solutions.
A recent study by Feltham et al. [74] demonstrated that foraging efficiency of bumble bees
dropped 31% when pollen was contaminated with sublethal levels (6 μg/kg) of imidacloprid
but no effect on nectar foraging when fed syrup at 0.7 μg/kg. It is difficult to directly relate
these results to those of our experiments because individual bees were exposed to single doses
and different endpoints were measured. In our studies, imidacloprid concentrations in bees
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reached average levels up to 3.7 μg/kg and 2.8 μg/kg, respectively, from colonies exposed to 20
and 100 μg/kg doses. Considering the rapid metabolism of imidacloprid by honey bees, forag-
ers were probably subjected to a chronic dose exposure of imidacloprid well exceeding levels
that might be encountered by feeding on nectar in imidacloprid seed-treated fields. Taken alto-
gether, these results provide evidence that continuous exposure of field relevant imidacloprid
doses had no significant effects on foraging activity at the colony level.
Effects on colony health. The presence of an active egg laying queen in pheromonal con-
trol of colony integrity, sufficient ratio of bees to brood to maintain population growth, rela-
tively disease/pest free, and adequate nutrition are principal determinants of a healthy honey
bee colony. Sublethal exposure to imidacloprid can affect these factors in many ways. In this
study, we monitored the performance of each colony by detailed assessments of bee population,
brood (capped cells and older larvae), beebread and stored honey during and after exposure
until the fall. We also recorded the percentage area of foundation with fully drawn cells as an
indicator of colony strength. In both years, development of the bee population and brood rear-
ing were not affected by the exposure doses. At the end of exposure in 2009, colonies among
treatment groups ranged in size from 21,298 to 24,160 bees and had ratios of 1.4 to 1.7 adult
bees to one capped brood cell. Ratios increased to nearly 3 in early October as brood rearing de-
clined and colonies prepared for overwintering. Colonies in 2010 were smaller in size ranging
from 13,393 to 15,435 bees at the end of exposure, with ratios of 1.1 to 2.3 adult bees to capped
brood. The percentages of frame area with beebread, capped honey and drawn cells showed no
statistically significant differences due to imidacloprid doses in both years. However, overall
dose relationship trends showed some evidence of an imidacloprid effect depending on the
study year. For example, the dose relationship with honey stores in 2009 using regression anal-
ysis was significant, indicating higher stores with increasing doses of imidacloprid and suggest-
ing that exposed colonies may have avoided the contaminated food. Based on results in
Table 1, the honey stores likely contained the highest concentrations of the insecticide. Bee
population and the portion of drawn cells were higher with increased dose in 2009, and bee-
bread stores decreased with dose in 2010. However, these regression relationships were
not significant.
The presence of diseases and pest species was not considered a significant stress factor af-
fecting colony health. Infection rates of parasitic mites and Nosema spores were low and nor-
mal for first year packaged colonies. However, Varroa infestations did show a significant dose
response in both years, and the 100 μg/kg treated colonies in 2009 had statistically higher mite
counts compared to counts in control colonies. This effect could possibly have greater impacts
on colony health if colonies are sublethally exposed to imidacloprid over multiple years, partic-
ularly since exposure to neonicotinoids can compromise immune defense responses in honey-
bees [75]. Despite these dose-related patterns, the general health of colonies based on all
endpoints taken together surprisingly showed no measureable differences among treatment
groups during or shortly after the exposure period. However, results did show evidence of de-
layed sublethal effects later in September, when several colonies exposed to the higher doses of
imidacloprid in 2009 became weak due to higher rates of queen loss and broodless periods.
These colonies could not recover after queen supersedure and either died out or were terminat-
ed to avoid robbing. One colony in each exposed group in 2010 also died out during late Sep-
tember due to lack of brood and stored food, despite being fed supplemental sucrose syrup. Of
the 2010 colonies that did survived to October, most imidacloprid-exposed colonies had nu-
merically fewer bees and less brood, beebread and honey going into the winter. Pooled over
both years, 100, 94.1, 82.4 and 82.4% of the colonies in the control, 5, 20 and 100 μg/kg treat-
ment groups, respectively, survived to the last inspection in October. Although not statistically
significant, this overall dose-dependent response strongly suggests that the higher imidacloprid
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doses had delayed sublethal effects on colony health. Time-to-effect studies have shown that
the effects of chronic exposure to relatively low doses of imidacloprid can accumulate in in-
sects, resulting in delayed toxicity [76].
Effects on overwintering. Requirements for successful overwintering of a honey bee colo-
ny include an adequate population to maintain cluster temperature, proper age of bees going
into the winter, and sufficient stores of honey and pollen. Each colony in 2009 and 2010 was
fed supplemental sucrose syrup during the fall to provision at least 30 kg of stored honey. How-
ever, many 2010 colonies in all treatment groups inspected in February were low in food stores
and had to be provisioned with bee candy. In both years, the proportion of colonies with a
queen and active brood nest observed in March was considered an indication of successful
overwintering. Results of the 2009 experiment suggested that chronic sublethal exposure to
imidacloprid during the summer weakened colonies and affected their ability to overwinter.
Average survival rates in control, 5, 20 and 100 μg/kg treatment groups in March were 100, 80,
70 and 60%, respectively. Relatively fewer colonies from the 2010 experiment survived the win-
ter, with only 57% of the control colonies survived compared to an overall 43% of the exposed
colonies. We contribute this higher mortality to subnormal colonies going into the winter and
abnormally higher temperatures during the winter which resulted in over-consumption of the
stored food. Additionally, the disproportionate queen losses early in the season and subsequent
reduced performance of the 2010 control colonies may have prejudiced the statistical analysis
of treatment effects. None of the dead-out colonies in both experiments showed evidence of
starvation or symptoms of colony collapse disorder, except several colonies in 2010 completely
lacked food and likely died from starvation.
Trends in colony survival with higher levels of imidacloprid exposure varied widely between
years. Statistical analyses of the proportion of colonies surviving each year showed no differ-
ences in 2010 and only the proportion surviving in the 100 μg/kg treated group was significant-
ly lower than that of the control colonies in 2009. However, statistical power was increased by
pooling the colony survival data over the October, February and March inspections of both
years. The logistic regression results of the combined data showed an overall significant dose
effect (F(3,15) = 4.21, p = 0.024), and all contrast tests comparing survival between control and
each treatment group were also significant, except for colonies exposed to 5 μg/kg. Pooled over
both years, colony survival in March averaged 82.4, 58.8, 47.1 and 52.9% in the control, 5, 20
and 100 μg/kg treatment groups, respectively (Fig. 9). These results, along with dose-response
patterns for several colony performance endpoints prior to overwintering, clearly indicate neg-
ative impacts on honey bee colony health due to the cumulative sublethal exposure to 20 and
100 μg/kg of imidacloprid for 12 weeks during the early summer. The delayed effect of reduced
winter survival was apparently due to higher rates of queen loss and broodless periods during
the late summer. Interestingly, the 2009 colonies entering the winter were seemingly stronger
than the 2010 colonies, yet they experienced winter mortality that was more positively associat-
ed with the level of imidacloprid exposure. We contribute this to the queenless situation that
probably resulted in a higher than normal proportion of old bees going into the winter. When
this occurs, although colony size may appear adequate in the fall, the bee cluster decreases
faster than brood rearing can compensate in February and March and the colony can fail. The
study by Sandrock et al. [63] also reported that queen failure significantly contributed to colony
weakening but not overwintering loss in colonies exposed over 1.5 months to pollen patties
contaminated with thiamethoxam and clothianidin at worst-case exposure scenarios for seed-
treated crops. Exposure doses in this study were comparable to our lowest dose of 5 μg/kg of
imidacloprid, which had no short-term effects on colony performance.
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Conclusions
To our knowledge, this study is the first to examine the chronic sublethal effects on whole
honey bee colonies subjected to worse-case scenarios as well as normal dietary exposure
(5μg/kg) to imidacloprid. We used spiked diet patties placed within colonies to deliver continu-
ous direct exposure over multiple brood cycles to imidacloprid residues that were generally
higher than levels found in bee-collected pollen and nectar under field conditions. Our results
provide evidence that imidacloprid exposure doses up to 100 μg/kg had no significant effects
on foraging activity or colony performance during and shortly after 12 weeks of exposure.
However, several colony performance endpoints showed dose-response patterns, particularly
higher Varroa infestations with increased dose, though not all patterns were statistically signifi-
cant. The major finding was the higher rates of queen replacement and resulting broodless pe-
riods during the late summer in colonies exposed to 20 and 100 μg/kg of imidacloprid, which
led to weaker colonies going into the winter. These exposure regimes sublethally affected colo-
ny health and significantly reduced overwintering success. However, the question remains as to
whether doses of 100 or even 20 μg/kg exposed for 12 continuous weeks realistically represent
imidacloprid residues in bee-collected food under agriculture settings. In certain field situa-
tions, residues of imidacloprid can reach or exceed 100 μg/kg in pollen of treated crops during
several weeks of flowering [35] or in guttation droplets exuded from treated corn seedlings
[45,46]. However, it is uncommon for honey bees to be exposed to these doses for extended pe-
riods. Furthermore, bees generally forage on different water and floral sources simultaneously
and not all sources will contain residues; thus their foraging behavior tends to reduce the con-
centration of imidacloprid in food stored in the colony. The within-hive fate experiment dem-
onstrated that imidacloprid residues of 100 μg/kg in diet patties or 20 μg/kg in sucrose syrup
became diluted or non-detectable due to the processing of beebread and honey and the rapid
metabolism of the chemical by bees. Given the weight of evidence presented here, we conclude
that chronic exposure to imidacloprid at the higher range of field doses (20 to 100 μg/kg) in the
pollen of certain treated crops could contribute to reduced overwintering success but the most
likely encountered field doses of 5 μg/kg, especially relevant for seed-treated crops, have
Fig 9. Proportion of colonies exposed for 12 weeks to untreated or imidacloprid-spiked diet patties
and survived to August (end of exposure), October, February and March (successful overwintering).
Means (±SE) pooled over both years are given for each exposure group and inspection month. Logistic
regression results for the overall dose effect (F(3, 15) = 4.21, p = 0.024; significant of differences between
control colonies and colonies exposed to 5 μg/kg (p = 0.201), colonies exposed to 20 μg/kg (p = 0.027), and
colonies exposed to 100 μg/kg (p = 0.027).
doi:10.1371/journal.pone.0118748.g009
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negligible effects on honey bee colony health. Currently there is wide agreement that sublethal
exposure to imidacloprid can cause adverse effects on honey bees in laboratory studies [77] but
no evidence that this widely used insecticide is the major stressor causing colony declines. Our
findings agree with a causal analysis by Staveley et al. [37] that judged neonicotinoid pesticides
to be an unlikely sole cause of colony declines. Finally, this study makes evident the importance
of conducting risk assessment studies on honey bee colonies over longer periods to reveal the
chronic sublethal effects on queen health and bee behaviors that can ultimately impair colony
performance [78].
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